These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 16284616)
1. Is there a role for high-dose methylprednisolone in the treatment of hepatic regimen-related toxicity? Hennenfent KL; Augustin KM; Dipersio JF; Khoury H Bone Marrow Transplant; 2006 Jan; 37(2):229. PubMed ID: 16284616 [No Abstract] [Full Text] [Related]
2. Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity? Khoury H; Adkins D; Brown R; Trinkaus K; Vij R; Miller G; Goodnough LT; DiPersio J Bone Marrow Transplant; 2000 Apr; 25(7):737-43. PubMed ID: 10745259 [TBL] [Abstract][Full Text] [Related]
3. High-dose methylprednisolone is effective in the management of acute graft-versus-host disease in severe combined immune deficiency. Somech R; Kavadas FD; Atkinson A; Grunebaum E; Roifman CM J Allergy Clin Immunol; 2008 Dec; 122(6):1215-6. PubMed ID: 18672279 [No Abstract] [Full Text] [Related]
4. Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone. Al Beihany A; Al Omar H; Sahovic E; Chaudhri N; Al Mohareb F; Al Sharif F; Al Zahrani H; Al Shanqeeti A; Seth P; Zaidi S; Morshed M; Al Anazi K; Mohamed G; Gyger M; Aljurf M Bone Marrow Transplant; 2008 Feb; 41(3):287-91. PubMed ID: 17982501 [TBL] [Abstract][Full Text] [Related]
5. High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Ratjen F; Rjabko O; Kremens B Bone Marrow Transplant; 2005 Jul; 36(2):135-8. PubMed ID: 15908967 [TBL] [Abstract][Full Text] [Related]
6. [Experience in the therapy of hepatic diseases of unfavorable evolution]. Güemes Díaz F Rev Clin Esp; 1967 Feb; 104(4):327-32. PubMed ID: 5597822 [No Abstract] [Full Text] [Related]
7. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation. Miki C; Gunson BK; Buckels JA; Uchida K; Mohri Y; Kusunoki M Ann Surg; 2009 Sep; 250(3):502-3; author reply 503-4. PubMed ID: 19730189 [No Abstract] [Full Text] [Related]
8. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation]. Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408 [TBL] [Abstract][Full Text] [Related]
9. Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease. Smith DL; Shire NJ; Watts NB; Schmitter T; Szabo G; Zucker SD J Clin Densitom; 2006; 9(1):105-13. PubMed ID: 16731439 [TBL] [Abstract][Full Text] [Related]
11. [Autologous bone marrow stem cell transplantation for treatment terminal liver diseases]. Pan XN; Shen JK; Zhuang YP; Chen XL; Li YX; Chen LJ; Yang H Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1207-9. PubMed ID: 18676264 [TBL] [Abstract][Full Text] [Related]
12. Management of hyperbilirubinemia in biliary atresia by hepatic progenitor cell transplantation through hepatic artery: a case report. Khan AA; Parveen N; Mahaboob VS; Rajendraprasad A; Ravindraprakash HR; Venkateswarlu J; Rao P; Pande G; Narusu ML; Khaja MN; Pramila R; Habeeb A; Habibullah CM Transplant Proc; 2008 May; 40(4):1153-5. PubMed ID: 18555137 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine. Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up. Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666 [TBL] [Abstract][Full Text] [Related]
15. [A new method for assessing hepatocyte glucuronyl-conjugating function]. Iastrems'ka OO; Romanyshyn IaM Fiziol Zh (1994); 1995; 41(5-6):117-9. PubMed ID: 9026384 [TBL] [Abstract][Full Text] [Related]
16. Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata. Kim BJ; Min SU; Park KY; Choi JW; Park SW; Youn SW; Park KC; Huh CH J Dermatolog Treat; 2008; 19(4):216-20. PubMed ID: 18608727 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning. Zaretsky Y; Rifkind J; Lockwood G; Tsang R; Kiss T; Hasegawa W; Fyles G; Tejpar I; Loach D; Minden M; Messner H; Lipton JH Bone Marrow Transplant; 2007 Sep; 40(5):423-30. PubMed ID: 17603516 [TBL] [Abstract][Full Text] [Related]
18. A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation. Xu X; Ling Q; Wu J; Chen J; Gao F; Feng XN; Zheng SS Liver Int; 2007 Aug; 27(6):816-24. PubMed ID: 17617125 [TBL] [Abstract][Full Text] [Related]
19. The use of megadose corticosteroids in traumatic optic neuropathy: case studies. Orticio LP Insight; 2003; 28(2):39-44; quiz 45-6. PubMed ID: 12889281 [No Abstract] [Full Text] [Related]
20. [Does hyperbilirubinemia in Meulengracht disease (Gilbert syndrome) need treatment?]. Beckh K Internist (Berl); 1994 Nov; 35(11):1075. PubMed ID: 7822130 [No Abstract] [Full Text] [Related] [Next] [New Search]